Advertisement
UK markets close in 45 minutes
  • FTSE 100

    8,049.30
    +4.49 (+0.06%)
     
  • FTSE 250

    19,746.32
    -53.40 (-0.27%)
     
  • AIM

    754.93
    +0.06 (+0.01%)
     
  • GBP/EUR

    1.1631
    +0.0003 (+0.03%)
     
  • GBP/USD

    1.2432
    -0.0020 (-0.16%)
     
  • Bitcoin GBP

    52,169.83
    -1,529.93 (-2.85%)
     
  • CMC Crypto 200

    1,413.32
    -10.78 (-0.76%)
     
  • S&P 500

    5,068.60
    -1.95 (-0.04%)
     
  • DOW

    38,426.07
    -77.62 (-0.20%)
     
  • CRUDE OIL

    83.38
    +0.02 (+0.02%)
     
  • GOLD FUTURES

    2,337.80
    -4.30 (-0.18%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • DAX

    18,109.47
    -28.18 (-0.16%)
     
  • CAC 40

    8,099.91
    -5.87 (-0.07%)
     

BUZZ-GSK dividend looks safe post-Brexit, even with new CEO

** Jefferies analysts upgrade GlaxoSmithKline (Other OTC: GLAXF - news) to buy from hold with 2,000p PT on growing confidence in drugmaker's 4.9% dividend yield. Stock up 1.5% at 1,670p

** Say fears of a dividend cut linked to the appointment of a new CEO are "overdone" and estimate 2015 payout ratio of 132% will fall to around 88% in 2016 and 63% in 2020, assuming continued flat divi

** GBP weakness post Brexit makes divi more secure, allaying investor concerns about group's ability to pay a promised 80p/share this year and next, and maintaining payouts beyond 2017

(RM (LSE: RM.L - news) :ben.hirschler.thomsonreuters.com@reuters.net)